Objective: To design and prepare a field battle "Windbreaker" stretcher for fixation of spinal cord injury using macromolecular material, and to determine its application index and assess its efficacy. Methods: Using shape memory waterborne polyurethaneurea/SiO2 nano-composite, we prepared a field battle "Windbreaker" stretcher for fixation of spinal cord injury according to the physique of the Chinese. The time spent to finish the fixation procedure under different conditions (raining, cold weather, land and rivers) was recorded, and the time of solidification was also observed. Results: The weight of a complete set of the field battle "Windbreaker" stretcher was (7.5±1.4) kg. The time to complete a fixation was (2.1±0.55) min in the water, (1.9±0.35) min under dry environment. The time of solidification was(7.7±1.45) min in the water and was (6.9±1.23) min under dry environment. The maximum strength the stretcher could bear was (80±5.7) kg. Conclusion: Our self-designed "Windbreaker" stretcher can be used for rapid and simple fixation of different spinal cord injuries, and the mechanics intensity meet the requirement for fixation. The stretcher can be used for fixation of spinal cord injury under different conditions of field battle.

Objective: To design a portable real-time monitoring tool for spine surgery and to preliminarily evaluate its application,so as to reduce the iatrogenic injury during the treatment of battle field spinal cord injury. Methods: A portable spine guiding device for spinal fixation was designed and prepared. The spinal specimens were randomly divided into control group (n = 10) and experimental group (n = 10). In the control group the way was cleared for the pedicle according to the doctor's experience; in the experimental group the way was cleared using our self-designed guiding device. The operation time was recorded in the two groups. After manipulation the specimens were opened along the pedicle level; the location and the depth of the needle were compared. Results;The manipulation time of a single vertebral body was (0. 5 + 0. 2) min in the control group and (0. 6 + 0. 1) min in the experimental group (P>0. 05). The edge of the puncture to the pedicle wall in the control group was significantly shorter than that in the experimental group ([1. 1 + 0. 3] vs [1. 8 + 0. 2] mm,P = 0. 037). Conclusion:The designed portable guiding device for spinal fixation is easy to carry, simple to operate; and initial in vitro application is satisfactory and can provide reliable reference for early operation.

We evaluated the effect of Tu-Chung (Eucommia ulmoides OLIV.) extract on anabolic action in castrated exercise and non-exercise rats in which the effects of male sex hormone from the testis were excluded. Castration was performed on 32 male Wistar rats aged 4 weeks. The rats were then divided into 4 groups: a non-exercise group treated with Tu-Chung extract (non Ex. Tu-chung G, n = 8), on exercise group treated with the extract (Ex. Tu-Chung G, n = 8), a non-exercise control group not treated with the extract (non Ex. Cont. G, n8), = and an untreated exercise control group (Ex. Cont. G, n=8) .
The Tu-Chung extract was administered orally at a dose of 1g/kg body weight once daily for 4 weeks. Distilled water was given by a similar method to the control groups. As the exercise load, the rats exercised on an animal treadmill at a starting speed of 20 m/min with an increase of 10 m/min every week for 30 min without rest daily for 4 weeks.
The following results were obtained:
1. The relative weight of the adrenal gland (gland weight/100 g body weight ) after 4 weeks was significantly higher in the non Ex. Tu-Chung G than in the non Ex. Cont. G (p<0.001) and in the Ex. Tu-Chung G than in the Ex. Cont. G or the non Ex. Cont. G (p<0.001 each) .
2. The relative weight of the kidneys (kidney weight/100 g body weight) after 4 weeks was significantly higher in the non Ex. Tu-Chung G than in the non Ex. Cont. G (p<0.001) and was slightly higher in the Ex. Tu-Chung G than in the Ex. Cont. G.
3. The relative weight of the musculus levator ani (muscle weight/100g body weight) after 4 weeks was significantly higher in the non Ex. Tu-Chung G than in the non Ex. Cont. G (p<0.001) and also in the Ex. Tu-Chung G than in the Ex. Cont. G (p<0.001) .
4. The 17-KS level in a 24h urine sample after 4 weeks was significantly higher in the non Ex. Tu-Chung G than in the non Ex. Cont. G or the Ex. Tu-Chung G (p<0.001 each) and also in the Ex. Tu-Chung G than in the Ex. Cont. G (p<0.001) .
5. The total urinary nitrogen level after 4 weeks was significantly lower in the non Ex. Tu-Chung G than in the non Ex. Cont. G (p<0.001) or the exercise group treated with the extract (p<0.05) and also in the Ex. Tu-Chung G than in the Ex. Cont. G (p<0.05) .
These results suggest that administration of Tu-Chung extract significantly increases the relative weight of the adrenal gland, enhances androgen secretion from the reticular layer of the adrenal cortex, and promotes protein anabolic action in castrated rats. In addition, this extract appears to increase the adaptation ability of the adrenal cortex to the stress caused by exercise.

We evaluated the effect of Tu-Chung (Eucommia ulmoides OLIV.) extract on anabolic action in castrated exercise and non-exercise rats in which the effects of male sex hormone from the testis were excluded. Castration was performed on 32 male Wistar rats aged 4 weeks. The rats were then divided into 4 groups: a non-exercise group treated with Tu-Chung extract (non Ex. Tu-chung G, n = 8), on exercise group treated with the extract (Ex. Tu-Chung G, n = 8), a non-exercise control group not treated with the extract (non Ex. Cont. G, n8), = and an untreated exercise control group (Ex. Cont. G, n=8) .
The Tu-Chung extract was administered orally at a dose of 1g/kg body weight once daily for 4 weeks. Distilled water was given by a similar method to the control groups. As the exercise load, the rats exercised on an animal treadmill at a starting speed of 20 m/min with an increase of 10 m/min every week for 30 min without rest daily for 4 weeks.
The following results were obtained:
1. The relative weight of the adrenal gland (gland weight/100 g body weight ) after 4 weeks was significantly higher in the non Ex. Tu-Chung G than in the non Ex. Cont. G (p<0.001) and in the Ex. Tu-Chung G than in the Ex. Cont. G or the non Ex. Cont. G (p<0.001 each) .
2. The relative weight of the kidneys (kidney weight/100 g body weight) after 4 weeks was significantly higher in the non Ex. Tu-Chung G than in the non Ex. Cont. G (p<0.001) and was slightly higher in the Ex. Tu-Chung G than in the Ex. Cont. G.
3. The relative weight of the musculus levator ani (muscle weight/100g body weight) after 4 weeks was significantly higher in the non Ex. Tu-Chung G than in the non Ex. Cont. G (p<0.001) and also in the Ex. Tu-Chung G than in the Ex. Cont. G (p<0.001) .
4. The 17-KS level in a 24h urine sample after 4 weeks was significantly higher in the non Ex. Tu-Chung G than in the non Ex. Cont. G or the Ex. Tu-Chung G (p<0.001 each) and also in the Ex. Tu-Chung G than in the Ex. Cont. G (p<0.001) .
5. The total urinary nitrogen level after 4 weeks was significantly lower in the non Ex. Tu-Chung G than in the non Ex. Cont. G (p<0.001) or the exercise group treated with the extract (p<0.05) and also in the Ex. Tu-Chung G than in the Ex. Cont. G (p<0.05) .
These results suggest that administration of Tu-Chung extract significantly increases the relative weight of the adrenal gland, enhances androgen secretion from the reticular layer of the adrenal cortex, and promotes protein anabolic action in castrated rats. In addition, this extract appears to increase the adaptation ability of the adrenal cortex to the stress caused by exercise.

This study examined the secretion capacity of the gonadal and adrenal cortex systems and the morphology of the adrenal cortex in male rats treated with Tu-chung (Eucommia ulmoides O_LIV) extract, the main component of Tu-chung extract, geniposide, or both agents during exercise load testing.
Twenty-four 4-week-old male Wistar rats were used. The rats were divided into four groups : those treated with Tu-chung extract and geniposide (n=7), those treated with Tu-chung extract (n=6), those treated with geniposide (n=7) and a control group treated with distilled water. The dose of each agent was 0.1 ml/100g body weight. The agents were administered orally for 25 days. For the exercise load test, a treadmill for small animals was used, with a tilting angle set at 0. Exercise load testing was performed for 30 min (2-min warm up and 28-min running) daily for 25 days. The running speed was 20 m/min for the first 5 days, and then increased by 5 m/min every 5 days.
The following results were obtained.
1. The relative weight of the adrenal gland (gland weight/100 g body weight) in the group treated with Tu-chung extract and geniposide was significantly higher than that in the group treated with geniposide or the control group (p<0.01) . The relative weight of the adrenal gland in the group treated with Tu-chung extract was significantly higher than that in the group treated with geniposide or the control group (p<0.01, p<0.001) . Furthermore, the relative gland weight in the group treated with geniposide was significantly higher than that in the control group (p<0.05) .
2. In the group treated with Tu-chung extract and geniposide, the group treated with Tu-chung extract and the group treated with geniposide, the relative gland weight of the testis (testis weight/100g body weight) was significantly higher than that in the control group (p<0.001) . However, there were no significant differences among the three groups.
3. The 24-h urinary excretion of 17-ketosteroid (17-KS) in the group treated with Tu-chung extract and geniposide was significantly higher than that in the group treated with Tu-chung extract, the group treated with geniposide or the control group (p<0.01, p<0.01, p<0.001) . In the group treated with geniposide, the 24-h urinary excretion of 17-KS was significantly higher than that in the control group (p<0.05) .
4. In the three groups treated with Tu-chung extract and/or geniposide, serum testosterone levels were significantly higher than those in the control group (p<0.001, p0.05, p<0.05) .
5. Concerning the morphology of the adrenal cortex, the thickness of the reticular layer of the adrenal cortex was most markedly increased in the group treated with Tu-chung extract and geniposide, followed in order by the group treated with Tu-chung extract, the group treated with geniposide and the control group.
Administration of Tu-chung extract and the main component of Tu-chung extract, geniposide, during exercise load testing significantly increased the weights of the adrenal gland and testis, and promoted testosterone secretion in the adrenal cortex reticular layer and testis.
These findings suggest that geniposide plays an important role in the pharmacological action of Tu-chung.

Animal models with kidney disease are generally divided into two types. One belongs to the models which imitate human kidney disease by the artificial operations, such as anti-glomerular basement membrane antibody nephritis, Heymann nephritis, anti-Thyl. 1 antibody nephritis, BSA nephritis and puromycin nephropathy. The other one pertains to the models which make themselves kidney disease, and appear the pathological characteristics naturally as like as human, such as HIGA mice with IgA nephropathy and NZB/WF1 and MRL/1pr mice with lupus nephritis. In addition,the transgenic animal models with kidney disease can also be established by the modern molecular biologic techniques including gene knockout and siRNA transfection. As for the studies related with kidney disease in pharmacodynamics and pharmacology of Chinese herbal medicine (CHM), it is important to understand deeply the features of each animal model with kidney disease, and select accurately the proper models according to the different experimental objectives, and then, build the special models provided with the combination of disease with syndrome in traditional Chinese medicine (TCM). Therefore,it is the developmental direction for the further study to establish animal models with kidney disease, which should possess the characteristics of syndrome in TCM.
Animals ; Diabetic Nephropathies ; etiology ; Disease Models, Animal ; Humans ; Kidney Diseases ; etiology ; Medicine, Chinese Traditional ; Mice ; Streptozocin

Traditional Chinese medicine Curcuma Zedoary ( E'Zhu) contains essential oil, curcuminoid and other effective constituents, with such pharmacological actions as anti-platelet aggregation, lowing blood lipid, anti-oxidation and anti-inflammation. In recent years, studies have showed that certain extracts and chemical components of E'Zhu could mitigate myocardial cell mitochondria injury and protect vascular endothelium by enhancing heme oxygenase-1 activity, inhibit nuclear factor NF-kappaB, target genes interleukin-associated kinase-1 (IRAK-1), tumor necrosis factor receptor-6 (TRAF-6) and vascular cell adhesion molecule-1 (VCAM-1), reduce inflammatory infiltration, and inhibit growth factor-induced smooth muscle cells (SMCs) proliferation and migration by impacting oxidation of cellular phosphatases. Due to its different functions in vascular endothelial cells and smooth muscle cells, E'Zhu has been applied in drug-eluting stents, with a potential effect in preventing in-stent restenosis and thrombogenesis. In this paper, studies on pharmacological effects and mechanisms of extracts and main chemical constituents from E'Zhu in preventing vascular restenosis were summarized.
Animals ; Constriction, Pathologic ; drug therapy ; prevention & control ; surgery ; Curcuma ; chemistry ; Drugs, Chinese Herbal ; chemistry ; pharmacology ; Endothelium, Vascular ; drug effects ; Humans ; Stents

AIM: To examine the relationship between corneal lymphangiogenesis and hemangiogenesis after keratoplasty.METHODS: Nineteen human corneas were obtained from 19 patients undergoing a second corneal transplantation in Zhongshan Ophthalmic Center in 2005. Blood and lymphatic vessels in human transplanted corneas were identified by lymphatic vessel endothelial receptor(LYVE-1) and platelet endothelial cell adhesion modecule-1(PECAM-1) immunohistochemistry, and double enzyme-histochemistry; then the association of corneal blood vessel counting (BVC) with lymphatic vessel counting (LVC) was examined.RESULTS: Corneal hemangiogenesis was present in 12 cases (63%), and lymphangiogenesis occurred in 5 cases (26%) of human transplanted corneas. In addition, corneal lymphangiogenesis was only present in vascularized corneas. LVC was strongly and positively correlated with BVC(r=0.725;P<0.01).CONCLUSION: Corneal lymphangiogenesis develops after keratoplasty, and strongly associates with hemangiogenesis.

OBJECTIVE The objective of this study is to discuss when to dissect the lymph nodes behind the right recurrent laryngeal nerve (LN-prRLN) from the standpoint of the right cervical level Ⅵ-1 (superficial layer to the recurrent laryngeal nerve) lymph nodes in papillary thyroid carcinoma (PTC) patients.METHODS The clinical data of 306 bilateral or right PTC patients from the Hangzhou First People's Hospital who underwent dissection of level Ⅵ-1 lymph nodes and LN-prRLN between March 2014 and September 2015 were analyzed. We measured the number of level Ⅵ-1 metastatic lymph nodes and size of level Ⅵ-1 lymph nodes metastasis loci to predict the metastasis of LN-prRLN.RESULTS The number of level Ⅵ-1 metastatic lymph nodes and size of level Ⅵ-1 lymph nodes metastasis loci were risk factors of LN-prRLN metastasis(P<0.05). When the number of the level Ⅵ-1 metastatic lymph nodes was greater than 1.5, the AUC was 0.813 (the sensitivity was 78.43%, the specificity was 76.65%). The ROC showed that when the size of level Ⅵ-1 lymph nodes metastasis loci were more than 0.45 cm, the AUC was 0.726 (sensitivity was 90.20%, specificity was 48.90%).CONCLUSION In bilateral or right PTC patients with metastasis of level Ⅵ-1 lymph nodes, especially when the number of level Ⅵ-1 metastatic lymph nodes was greater than 2cm and the metastasis loci were more than 0.45 cm, we should dissect the LN-prRLN.

Background Placement of an orbital implant is a main way to prevent orbital atrophy with aging.But its mechanism is under clear.Researchs showed that bone growth factors play important role during the development and repair of bone,especially transforming growth factor-β1(TGF-β1).Objective Present study was to investigate the expression of TGF-β1 protein in orbital bone after enucleation or enucleation with placement of an orbital implant and its function in the mechanisms of preventing and treating the orbital malformed development after enucleation with placement of an orbital implant.Methods Twenty-one age- and weight-matched New Zealand white young rabbits were randomly divided into the enucleation,implant and control groups,and each group including seven rabbits.Eyeball nucleation surgery was performed in the left eyes of 7 1-month-old rabbits,and a spherical orbital implant was inserted after enucleation of the left in matched rabbits in implant group.The left eye of normal rabbits served as controls.The rabbits were sacrificed in 1 month after surgery.The expression of TGF-β1 protein in the left orbital bone was detected using enzyme immunoassay and FITC labelling immunoassay technique in the sections of zygomatic bones.The content of TGF-β1 protein in the left orbital bone tissue was measured by ELISA method.This use of animals complied with the Regulations for the Administration of Affair Concerning Experimental Animals by State Science and Technology Commission.Results The height and width of orbital in enucleation group were significantly lower than those of implant and normal control groups(height:P=0.00,P=0.00;width:P =0.00,P=0.00).The positive bone cells of both enzyme immunoassay and FITC staining were increased in the implant and control groups in comparison with enucleation group,but the positive response intensity for TGF-β1 was resembled between implant group and control group.ELISA result revealed that the content of TGF-β1 protein in bone tissue was significantly lower in the enucleation group than in implant and control groups(P=0.00,P=0.00).The expression and content of TGF-β1 protein in bone tissue is similar between the implant group and the control group(P=0.41). Conclusion The experiment results indicate that TGF-β1 protein participate in the orbital development.TGF-β1 played important role in the prevention and treatment of enucleation-induced orbital malformation in the eye with placement of an orbital implant.